AI assistant
Sending…
BioLineRx Ltd. — Capital/Financing Update 2018
Jan 22, 2018
6692_rns_2018-01-22_0a1897dd-a237-45fb-87c9-6a80b45b870a.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 19, 2018 4:30 P.M. Form: F-3 CIK: 0001498403
Company Name: BioLineRx Ltd.
File Number: 333-222332
More from BioLineRx Ltd.
Report Publication Announcement
2026
Apr 28
Regulatory Filings
2026
Apr 28
Foreign Filer Report
2026
Apr 28
Report Publication Announcement
2026
Mar 29
Regulatory Filings
2026
Mar 29
Annual Report
2026
Mar 27
Report Publication Announcement
2026
Mar 26
Regulatory Filings
2026
Mar 26
Foreign Filer Report
2026
Mar 26
Report Publication Announcement
2026
Mar 23